Blood Testing Equipment Market

By Product Type;

Blood Analyzers, Point-Of-Care Testing Devices and Reagents & Kits

By Technology;

Immunoassay, Hematology, Molecular Diagnostics and Clinical Chemistry

By End User;

Hospitals & Clinics, Diagnostic Laboratories, Research Institutions and Home Care Settings

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn309535606 Published Date: September, 2025 Updated Date: October, 2025

Blood Testing Equipment Market Overview

Blood Testing Equipment Market (USD Million)

Blood Testing Equipment Market was valued at USD 8559.42 million in the year 2024. The size of this market is expected to increase to USD 12870.20 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.


Blood Testing Equipment Market

*Market size in USD million

CAGR 6.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.0 %
Market Size (2024)USD 8559.42 Million
Market Size (2031)USD 12870.20 Million
Market ConcentrationMedium
Report Pages384
8559.42
2024
12870.20
2031

Major Players

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Nihon Kohden Corporation
  • Mindray Bio-Medical Electronics Co., Ltd

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Blood Testing Equipment Market

Fragmented - Highly competitive market without dominant players


The Blood Testing Equipment Market is expanding as healthcare systems increasingly depend on precise diagnostics for patient care. More than 45% of medical diagnoses are supported by advanced blood testing methods, making them vital in clinical decision-making. Demand for reliable and efficient equipment continues to rise as providers focus on error reduction and faster results.

Automation and Technological Advancements
Laboratories are rapidly embracing automation, with nearly 55% adopting automated analyzers to enhance workflow efficiency. These technologies reduce manual effort, improve accuracy, and cut testing time significantly. Portable and point-of-care systems are also reshaping the market, recording an adoption growth of 30% in both clinical and at-home healthcare environments.

Digital and Connected Testing Solutions
The rise of connected healthcare is transforming blood testing, with close to 50% of devices now featuring integration with mobile platforms and cloud-based systems. Real-time reporting, AI-powered analytics, and remote monitoring are enabling faster and more personalized care. Such advancements make diagnostic processes more patient-centric and accessible.

Expanding Reach Through Accessibility
Compact and easy-to-use diagnostic equipment is broadening accessibility, with nearly 35% higher adoption among smaller healthcare facilities and clinics. These developments are making high-quality blood testing available to a larger patient base. By combining affordability with innovation, the market is steadily moving toward universal access to advanced diagnostics.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Blood Testing Equipment Market
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements
        2. Rising healthcare demand
        3. Growing geriatric population
        4. Increasing chronic diseases
        5. Focus on preventive care
      2. Restraints
        1. Cost constraints
        2. Regulatory complexities
        3. Limited access
        4. Accuracy challenges
        5. Competition pressure
      3. Opportunities
        1. Emerging markets growth
        2. Remote healthcare services
        3. Personalized medicine trend
        4. AI integration
        5. Point-of-care testing
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Blood Testing Equipment Market, By Product Type, 2021 - 2031 (USD Million)
      1. Blood Analyzers
      2. Point-Of-Care Testing Devices
      3. Reagents & Kits
    2. Blood Testing Equipment Market, By Technology, 2021 - 2031 (USD Million)
      1. Immunoassay
      2. Hematology
      3. Molecular Diagnostics
      4. Clinical Chemistry
    3. Blood Testing Equipment Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Research Institutions
      4. Home Care Settings
    4. Blood Testing Equipment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott Laboratories
      2. Roche Diagnostics (F. Hoffmann-La Roche Ltd)
      3. Bio-Rad Laboratories
      4. bioMérieux
      5. Danaher Corporation
      6. Quest Diagnostics
      7. Siemens Healthineers
      8. Becton, Dickinson and Company (BD)
      9. Grifols
      10. Trinity Biotech
      11. Hologic
      12. Beckman Coulter
      13. Thermo Fisher Scientific
      14. Biomerica
      15. Sysmex Corporation
  7. Analyst Views
  8. Future Outlook of the Market